January 21, 2021 Clinical Research/Diagn. M&A, Partnerships Mass Spectrometry

SCIEX Acquires Intabio, a developer of precision solutions for biotherapeutic analysis through imaged cIEF-MS

Innovative charged variant analysis accelerates biologic drug development, ensuring drug safety and efficacyJanuary 21, 2021 12:00 PM Eastern Standard Time FRAMINGHAM, Mass.–(BUSINESS WIRE)–SCIEX, a global leader in life science analytical technologies, announced the closing of its acquisition of Intabio, Inc., a privately held company and the developer of the Blaze™ System for biotherapeutic analysis and quality... Read more

April 8, 2020 Bio/Pharma/CRO M&A, Partnerships Mass Spectrometry

SCIEX and Intabio Collaborate to Accelerate Biopharma Drug Development

Collaboration on Novel iCIEF-MS Platform speeds up critical decisions and streamlines approaches in biopharma environment April 08, 2020 Framingham, MA and Newark, CA — SCIEX, a global leader in life science analytical technologies, and Intabio, a developer of innovative instrumentation systems for biotherapeutic precision analysis and quality assessment, announced a collaboration to couple Intabio’s Blaze™ system with... Read more